Summary
Malaria prevention is a main challenge for physicians, nurses, health officers and tour operators. The attack rate of malaria in travellers is 1–10/10,000 departures, and the case fatality rate of imported malaria is around 0.5/100. Travellers should be informed about the risk they are going to take, how to protect against mosquito bites, about the antimalarials they will have to take and about what to do when a malaria breakthrough should occur.
The 4-aminoquinolines (chloroquine, amodiaquine) remain the drug of choice for the prevention ofPlasmodium vivax and of sensitiveP. falciparum infections. The problem is to find an effective and safe drug combination for travellers to areas whereP. falciparum is either resistant to chloroquine, to Fansidar (the combination of pyrimethamine plus sulfadoxine) or to both. These travellers will probably best be protected by an individually tailored drug combination, which includes amodiaquine or mefloquine as baseline drugs, and a supplementation with Fansidar, Maloprim (the combination of pyrimethamine with dapsone), paludrine or an antibiotic.
Similar content being viewed by others
References
Bengtsson, E., Bjorkman, A., Brohult, J., Hedman, P., Persson, P., Rombo, L., and Wahlgren, M., Malaria prophylaxis when visiting areas of East Africa with chloroquine resistance. Lancet2 (1981) 249.
Boudreau, E.F., Webster, H.K., Pavanand, K., and Thosingha, L., Type II mefloquine resistance in Thialand. Lancet2 (1982) 1335.
Bray, R.S., and Garnham, P.C.C., The life cycle of primate malaria parasites. Br. med. Bull.38 (1982) 117–122.
Bruce-Chwatt, L.J., Essential malariology. W. Heinemann Medical Books Ltd., London 1980.
Bruce-Chwatt, L.J., Black, R.H., Canfield, C.J., Clyde, D.F., Peters, W., and Wernsdorfer, W.H., Chemotherapy of malaria, 2nd edn. WHO, Geneva 1981.
Bruce-Chwatt, L.J., Man against malaria; conquest or defeat, Trans. R. soc. trop Med. Hyg.73 (1979) 605–617.
Campbell, C.C., Payne, D., Schwartz, I.K., and Khatib, O.J., Evaluation of amodiaquine treatment of chloroquine-resistant Plasmodium falciparum malaria on Zanzibar, 1982. Am. J. trop. Med. Hyg.32 (1983) 1216–1220.
CDC, Health information for international travel. Morbid. Mortal. Wkly Rep.31 (1982) suppl.
Colbourne, M.J., Malaria prophylaxis for long-term visitors. Comm. Dis. Rep.35 (1983) 3–4.
Colbourne, M.J., Malaria prophylaxis for visitors to south-east Asia and south-west Pacific. Comm. Dis. Rep.1 (1984) 3–4.
Dixon, K.E. Williams, R.G., Pongsupat, T., Pitaktong, U., and Phintuyolkin, P., A comparative trial of mefloquine and Fansidar in the treatment of falciparum malaria: failure of Fansidar. Trans. R. Soc. trop. Med. Hyg.76 (1982) 664–667.
Espinal, C.A., Uribe, L.M., Eslava, A., Rodriguez, M.E., Resistencia del plasmodium falciparum a combinación sulfa-pirimentamina. Descripción de los tres primeros casos en Colombia. Biomédica1 (1981) 213–217.
Hansford, C.F., and Hoyland, J., An evaluation of co- trimoxazole in the treatment of Plasmodium falciparum malaria. S. Afr. med. J.61 (1982) 512–514.
Holvoet, G., Michielsen, P., and Vandepitte, J., Airport malaria in Belgium. Lancet2 (1982) 881–882.
Jiang J.B., Li, G.Q., Guo, X.B., Kong, Y.C., and Arnold, K., Antimalarial activity of mefloquine and quinghaosu. Lancet2 (1982) 285–288.
Johnson, D.E., Roendej, P., and Williams, R.G., Falciparum malaria acquired in the area of the Thai-Khmer border resistant to treatment with Fansidar. Am. J. trop. Med. Hyg.31 (1982) 907–912.
Lapierre, J., Devant, J., Coquelin, B., Faurant, C., and Galal, A.A., Evaluation of experimental use of mefloquine for chemoprophylaxis of malaria in democratic Kampuchea (Kampuchean-Thai frontier region). WHO unpublished document, WHO/MAL/83.993 1983.
McElnay, J.C., Mukhtar, H.A., D'Arcy, P.F., Temple, D.J., and Collier, P.S., The effect of magnesium trisilicate and kaolin on the in vivo absorption of chloroquine. J. trop. Med. Hyg.85 (1982) 159–163.
Neumann, H.H., Malaria prophylaxis with chloroquine. Lancet2 (1981) 1231.
Noeypatimanond, S., Malikul, S., Benjapong, W., Duiyanada, D., and Ungkasrithongkul, M., Treatment of Plasmodium falciparum malaria with a combination of amodiaquine and tetracycline in Central Thailand. Trans. R. Soc. trop. Med. Hyg.77 (1983) 338–340.
Olsen, V.V., Why not proguanil in malaria prophylaxis? Lancet1 (1983) 649.
Pinichpongse, S., Doerstyn, E.B., Cullen, J.R., Yisunsri, L., Thongsombun, Y., and Thimasarn, K., An evaluation of five regimens for the outpatient therapy of Falciparum malaria in Thailand 1980–1981. Bull. WHO60 (1982) 907–912.
Phillips, R.E., Looareesuwan, S., Karbwang, J., Warrell, D.A., White, N.J., Kasemsarn, P., and Warhurst, D.C., Failure of chloroquine-erythromycin and chloroquine-tetracycline combinations in treatment of chloroquinine-resistant falciparum malaria in eastern Thailand. Lancet1 (1984) 300–302.
Rieckmann, K.H., Falciparum malaria: the urgent need for safe and effective drugs. A. Rev. Med.34 (1983) 321–335.
Ritschel, W.A., Hammer, G.V., and Thompson, G.A., Pharmacokinetics of antimalarials and proposals for dosage regimens. Int. J. clin. Pharmac.6 (1978) 395–401.
Schwartz, I.K., Payne, D., Campbell, C.C., and Khatib, O.J., Invivo and in-vitro assessment of chloroquine-resistant plasmodium falciparum malaria in Zanzibar. Lancet1 (1983) 1003–1005.
Senior, R., The world travel market, pp. 1–250. Euromonitor Publ. Ltd. London 1982.
Smrkovski, L.L., Buck, R.L., Alcantara, A.K., Rodriguez, C.S., and Üylanco, C.V., In vitro mefloquine resistant Plasmodium falciparum from the Philippines. Lancet2 (1982) 322.
Smrkovski, L.L., Hoffman, S.L., Purnomo, Hussein, R.P., Masbar, S., and Kurniawan, L., Chloroquine resistant Plasmodium falciparum on the island of Flores, Indonesia. Trans. R. Soc. trop. Med. Hyg.77 (1983) 459–462.
Spencer, H.C., Kipingor, T., Agure, R., Koech, D.K. and Chulay, J.D., Plasmodium falciparum in Kisumu, Kenya:, differences in sensitivity to amodiaquine and chloroquine in vitro. J: Infect. Dis.148 (1983) 732–736.
Stahel, E., Degrémont, A., and Lagler, U., Pyrimethamine-sulfadoxine resistant falciparum malaria acquired at Dar es Salaam. Lancet1 (1982) 1118–1119.
Stürchler, D., Endemiegebiete tropischer Infektionskrankheiten. H. Huber Verlag, Bern 1981.
WHO, World malaria situation 1981, Reprinted from, WHO Wkly Epidem. Rec.58 (1983) 189–192, 198–199, 206–209, 214–216, 222–224, 232–233.
WHO, Vaccination certivicate requirements for international travel and health advice to travellers. WHO, Geneva 1983.
Watkins, W.M., Sixsmith, D.G., Spencer, H.C., Boriga, D.A., Kariuki, D.M., Kipingor, T., and Koech, D.K., Effectiveness of amodiaquine as treatment for chloroquine-resistant plasmodium falciparum infections in Kenya. Lancet2 (1984) 357–359.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Stürchler, D. Malaria prophylaxis in travellers: The current position. Experientia 40, 1357–1362 (1984). https://doi.org/10.1007/BF01951889
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01951889